Is ELV or LLY cheaper?

On trailing earnings, ELV is cheaper: ELV trades at a 17.19 P/E and LLY at 40.25.

Which has grown faster, ELV or LLY?

Over the past five years, LLY grew revenue faster — ELV at a 9.97% CAGR versus LLY at 23.17%.

Does ELV or LLY pay a bigger dividend?

ELV yields 1.70% and LLY yields 0.57% based on trailing dividends and the latest price.

Is ELV or LLY more profitable?

LLY runs the higher net margin — ELV at 2.62% versus LLY at 34.98%.

Which has been the better investment, ELV or LLY?

Over the past 10-year, LLY delivered the higher annualized total return — ELV at 13.43% versus LLY at 33.50%. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Eli Lilly and Company (LLY)

LLY leads on 10 of 17 compared metrics, though ELV is the cheaper stock.

A side-by-side comparison of Elevance Health Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Eli Lilly and Company

$1.07T

$1133.00Healthcare

Total return — ELV vs LLY

growth of $100 · last 25y

ELV +1875.9%LLY +1366.3%ELV compounded faster

ELV LLY

ELV vs LLY: by the numbers

•LLY is the larger company ($1.07T vs $87.75B market cap).
•ELV trades at the lower earnings multiple (17.19 vs 40.25 P/E).
•LLY converts more revenue to profit (34.98% vs 2.62% net margin).
•LLY grew revenue faster over the past five years (23.17% vs 9.97% CAGR).
•ELV pays the higher dividend yield (1.70% vs 0.57%).

Which is better, ELV or LLY?

Metric tally: ELV 7 · LLY 10

It depends on what you're optimizing for:

ValueELV(lower P/E)

GrowthLLY(faster 5Y revenue CAGR)

IncomeELV(higher dividend yield)

QualityLLY(higher ROIC)

Valuation

Metric	ELV	LLY
P/E ratio	17.19●	40.25
Forward P/E	13.82●	25.41
P/S ratio	0.44●	14.05
P/B ratio	2.03●	32.54
PEG ratio	2.58	0.49●
EV / EBITDA	12.48●	31.47
FCF yield	7.24%●	1.34%

Profitability

Metric	ELV	LLY
Gross margin	23.16%	83.51%●
Operating margin	3.81%	45.87%●
Net margin	2.62%	34.98%●
ROE	11.94%	81.01%●
ROIC	6.65%	30.20%●

Dividends

Metric	ELV	LLY
Dividend yield	1.70%●	0.57%
Payout ratio	27.24%	28.09%

Growth (annualized)

Metric	ELV	LLY
Revenue CAGR (5Y)	9.97%	23.17%●
EPS CAGR (5Y)	6.67%	28.88%●
FCF CAGR (5Y)	-7.76%	19.54%●
Total return CAGR (5Y)	2.50%	39.57%●

Frequently asked

Which is better, ELV or LLY?: It depends on your goal. value: ELV (lower P/E); growth: LLY (faster 5Y revenue CAGR); income: ELV (higher dividend yield); quality: LLY (higher ROIC). Across all compared metrics, LLY leads 10 to 7.
Is ELV or LLY cheaper?: On trailing earnings, ELV is cheaper: ELV trades at a 17.19 P/E and LLY at 40.25.
Which has grown faster, ELV or LLY?: Over the past five years, LLY grew revenue faster — ELV at a 9.97% CAGR versus LLY at 23.17%.
Does ELV or LLY pay a bigger dividend?: ELV yields 1.70% and LLY yields 0.57% based on trailing dividends and the latest price.
Is ELV or LLY more profitable?: LLY runs the higher net margin — ELV at 2.62% versus LLY at 34.98%.
Which has been the better investment, ELV or LLY?: Over the past 10-year, LLY delivered the higher annualized total return — ELV at 13.43% versus LLY at 33.50%. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full LLY analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Eli Lilly and P/E ratio Elevance Health dividend yield Eli Lilly and dividend yield Elevance Health ROE Eli Lilly and ROE Elevance Health operating margin Eli Lilly and operating margin Elevance Health revenue growth Eli Lilly and revenue growth Elevance Health free cash flow Eli Lilly and free cash flow

Elevance Health & Eli Lilly and appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.